The Rogosin Institute Inc

EIN: 133184198 501(c)(3) Health Care

New York, NY

Total Revenue
$118,417,253
Total Expenses
$122,658,383
Total Assets
$116,787,782
Net Assets
$16,043,473
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1990
Legal Domicile
NY
Phone
2127461551
Tax Period
2023-01-01 to 2023-12-31

The Rogosin Institute Inc, founded in 1990, is a major nonprofit in the Health Care sector that reported $118.4M in total revenue in fiscal year 2023.

Mission

TO PROVIDE PREVENTIVE AND TREATMENT SERVICES ACROSS THE SPECTRUM OF KIDNEY DISEASE; CONDUCT BASIC AND CLINICAL RESEARCH IN RENAL AND CARDIOVASCULAR DISEASES, DIABETES, CANCER, OUTCOME RESEARCH AND POLICY FORMULATION.

Program Service Accomplishments

Program 1
Expenses: $78,577,578 Revenue: $93,346,000

DIALYSIS FACILITY: Provides in-center, home hemodialysis and peritoneal dialysis services for patients with kidney failure (end-stage kidney disease) through 10 centers in New York City, Brooklyn...

Read more

DIALYSIS FACILITY: Provides in-center, home hemodialysis and peritoneal dialysis services for patients with kidney failure (end-stage kidney disease) through 10 centers in New York City, Brooklyn, Queens and the Bronx.

Program 2
Expenses: $14,916,631 Revenue: $15,001,416

IMMUNOGENETICS AND TRANSPLATATION CENTER: A HISTOCOMPATIBILITY LABORATORY THAT PERFORMS TISSUE TYPING EVALUATIONS TO FACILITATE ORGAN TRANSPLANTATION.

Program 3
Expenses: $4,185,543 Revenue: $2,318,985

RESEARCH: basic science and clinical research program studying kidney disease, renal replacement therapy (dialysis, kidney transplantation) and regenerative medicine. The program develops and tests...

Read more

RESEARCH: basic science and clinical research program studying kidney disease, renal replacement therapy (dialysis, kidney transplantation) and regenerative medicine. The program develops and tests new therapeutic modalities for kidney disease and its causes, including diabetes, lipid disorders and cardiovascular disease.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $4,297,607
Program Service Revenue $111,658,396
Investment Income $-72,838
Other Revenue $2,534,088
TOTAL REVENUE $118,417,253

Expense Breakdown

Grants Paid $1,175,793
Salaries & Benefits $69,084,756
Fundraising Expenses $1,187,522
Program Expenses $99,252,475
Other Expenses $52,397,834
TOTAL EXPENSES $122,658,383

Year-over-Year Comparison

2023 2022 Change
Revenue $118,417,253 $116,515,923 +0.0%
Expenses $122,658,383 $123,934,554 0.0%
Net Income $-4,241,130 $-7,418,631 -0.4%
Key Indicators
✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
23
Independent Members
9
Employees
599
Volunteers
N/A

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
11
$8,071,539
Total Directors
28
$18,665,996
Key Employees
2
$667,941
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
N/A EVP/CLINICAL SERVICE & STRATEGY 60.0
Officer Director
$488,756 $24,458 $513,214
N/A VP NEPHROLOGY/DIALYSIS & CMO 60.0
Officer Director
$479,239 $24,990 $504,229
N/A VICE CHAIR 1.0
Officer Director
$0 $66,392 $1,532,837
N/A TREASURER 1.0
Officer Director
$0 $67,757 $1,229,582
N/A CHARIMAN 5.0
Officer Director
$0 $0 $0
N/A SECRETARY 1.0
Officer Director
$0 $61,522 $1,771,705
N/A VP NEPHROLOGY/CONSULTIVE SVCS 60.0
Officer Director
$577,581 $54,809 $632,390
N/A DIRECTOR 1.0
Director
$0 $0 $0
N/A DIRECTOR 1.0
Director
$0 $79,670 $633,556
N/A DIRECTOR 1.0
Director
$0 $0 $0
N/A DIRECTOR 1.0
Director
$0 $48,415 $868,927
N/A DIRECTOR 1.0
Director
$0 $0 $0
N/A DIRECTOR (THRU 6/2023) 1.0
Director
$0 $0 $0
N/A DIRECTOR 1.0
Director
$0 $0 $0
N/A DIRECTOR 1.0
Director
$0 $73,516 $1,019,207
N/A DIRECTOR 1.0
Director
$0 $0 $0
N/A DIRECTOR 1.0
Director
$0 $75,131 $1,186,467
N/A DIRECTOR 5.0
Director
$0 $0 $0
N/A DIRECTOR 1.0
Director
$0 $0 $0
N/A DIRECTOR 1.0
Director
$0 $74,378 $887,623
N/A DIRECTOR (THRU 6/2023) 1.0
Director
$0 $43,727 $1,779,024
N/A DIRECTOR 1.0
Director
$0 $80,466 $1,137,742
N/A DIRECTOR 1.0
Director
$0 $0 $0
N/A DIRECTOR (THRU 7/2023) 1.0
Director
$0 $65,527 $1,171,279
N/A DIRECTOR (THRU 6/2023) 1.0
Director
$0 $47,861 $732,460
N/A DIRECTOR (THRU 12/8/2023) 1.0
Director
$0 $29,038 $625,773
N/A DIRECTOR 1.0
Director
$0 $77,171 $1,973,956
N/A DIRECTOR 1.0
Director
$0 $45,526 $466,025
N/A EVP/COO 35.0
Officer
$461,801 $23,681 $485,482
N/A VP INFO. TECH./CIO 35.0
Officer
$341,225 $46,213 $387,438
N/A PRESIDENT 58.0
Officer
$0 $49,687 $933,128
N/A VP DEVELOP & PUBLIC AFFAIR 35.0
Officer
$75,782 $5,752 $81,534
N/A HR DIRECTOR 35.0
Key Emp
$206,438 $21,153 $227,591
N/A LAB DIRECTOR 35.0
Key Emp
$416,933 $23,417 $440,350
N/A PHYSICIAN 35.0
Highest
$432,786 $54,306 $487,092
N/A PHYSICIAN 35.0
Highest
$425,987 $18,829 $444,816
N/A PHYSICIAN 35.0
Highest
$382,524 $56,395 $438,919
N/A PHYSICIAN 35.0
Highest
$419,484 $33,211 $452,695
N/A PHYSICIAN 39.0
Highest
$462,240 $67,879 $786,019
N/A FORMER KEY EMPLOYEE 35.0
$242,752 $32,691 $275,443
N/A FORMER KEY EMPLOYEE 35.0
$233,387 $10,598 $243,985
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $118,417,253 $122,658,383 $116,787,782 $-4,241,130
2022 $116,515,923 $123,934,554 $117,935,683 $-7,418,631
2021 $118,085,739 $119,698,006 $82,482,762 $-1,612,267
2020 $114,237,768 $118,803,384 $90,432,810 $-4,565,616
2019 $110,922,475 $114,249,541 $84,015,491 $-3,327,066
2018 $102,030,839 $105,745,432 $81,135,504 $-3,714,593
Explore More Nonprofits
→Top 100 Nonprofits in New York →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare The Rogosin Institute Inc with other nonprofits in New York and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.